Sanket Koul

NMC has asked medical colleges to set up sub-committees to monitor prescription practices and stress clear, legible handwriting as part of medical training.

Lack of clarity on funding of higher education institutes was raised by several experts

The introduction of the bill faced sharp resistance from the opposition

Analysts say IHH's play may include improving revenue per bed by lifting clinical mix

Golden Growth Fund said it has deployed Rs 58 crore to acquire two South Delhi projects in Anand Niketan and Niti Bagh for luxury floors, with an estimated sales potential of Rs 85 crore

Entry of generics post March 2026, patient dropouts to affect sales values, say experts

With Mounjaro gaining ground, launch comes just three months before Novo loses patent for semaglutide

Novo Nordisk's appeal is listed for hearing on Friday before a bench of Justice C Hari Shankar and Justice Om Prakash Shukla

University College London sees a 19-26% surge in Indian student enrolments for academic year 2025-26, focusing on partnerships and scholarships instead of a foreign campus

A bipartisan parliamentary forum has warned that funding shortages and administrative delays under India's rare disease policy are disrupting life-saving treatment

The Delhi High Court has allowed Sun Pharma to manufacture and export semaglutide-based drugs to countries where Novo Nordisk holds no patent, but barred sales in India until March 2026

The dispute centres on Novo Nordisk's Indian patents for semaglutide, which it markets globally as Ozempic and Wegovy for Type 2 diabetes and weight management

Ghost malls hold over Rs 350 crore in annual rental potential: Knight Frank report

Novo Nordisk cut Wegovy prices in mid-November, driving a 70% consumption jump and higher market share. Pharmarack data show Lilly's Mounjaro still dominates sales

Winter triggered ailments no longer just a seasonal fluctuation but an escalating public health trigger due to air pollution, say experts

According to the agreement, Immutep will receive from Dr Reddy's an upfront payment of $20 million (around AUD 30.2 million)

Industry says earmarking funds for public health at par with national security will help channel revenue for public health infra

A leading rare disease group urges India to adopt a Russia-style dedicated fund and tax-based model to ensure sustained treatment support beyond the current ₹50-lakh cap

The company said that the project will have a total development cost of ₹2,000 crore, with the gross sale value projected at over ₹3,000 crore

GCC healthcare ecosystem projected to require over 50,000 additional nurses by 2027, says BorderPlus CEO